Concurrent DNA hypomethylation and epigenomic reprogramming driven by androgen receptor binding in bladder cancer oncogenesis
CUT&Tag sequencing reveals how the androgen receptor (AR) drives tumor heterogeneity and gender disparities in bladder cancer through epigenetic reprogramming.